CARDINAL HEALTH INC
CAHCardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How CAH's past catalysts played out
Empagliflozin 10 mg
Acute Myocardial Infarction
Tc99m tilmanocept
Rhabdomyosarcoma
Drug: G.S.P. Solution 400 mg/ml I.V. 1.25 ml/kg BW G.S.P. solution after fasting for 6 hours.
Galactose Single Point (GSP), Residual Liver Function
Loxoprofen Pain Patch
Delayed Onset Muscle Soreness
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Empagliflozin 10 mg | Phase 3 | Acute Myocardial Infarction | - | - |
Tc99m tilmanocept | Phase 2 | Rhabdomyosarcoma | - | - |
Drug: G.S.P. Solution 400 mg/ml I.V. 1.25 ml/kg BW G.S.P. solution after fasting for 6 hours. | Phase 2 | Galactose Single Point (GSP), Residual Liver Function | - | - |
Loxoprofen Pain Patch | Phase 2 | Delayed Onset Muscle Soreness | - | - |
Frequently asked questions
What is in CARDINAL HEALTH INC's drug pipeline?→
CatalystAlert tracks 4 drug candidates in CARDINAL HEALTH INC's (CAH) pipeline across Phase 3, Phase 2. Its lead program is Empagliflozin 10 mg (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CARDINAL HEALTH INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CARDINAL HEALTH INC (CAH) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CAH biotech catalysts?→
Add CAH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CARDINAL HEALTH INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.